Design, synthesis, and evaluation of anxiolytic activity of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole derivatives

Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervo...

Full description

Saved in:
Bibliographic Details
Published inFuture journal of pharmaceutical sciences Vol. 10; no. 1; pp. 50 - 9
Main Authors Mahajan, Bhavna Sunil, Kawale, Laxman A., Nade, Vandana S., Unavane, Supriya, Sajimon, Lida, Kapadnis, Prajakta
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 29.03.2024
Springer Nature B.V
SpringerOpen
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervous system. This study aimed to design, molecularly dock, synthesize, and assess the anxiolytic potential of six derivatives of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole. Results In the present study, an attempt was made to synthesize benzimidazole derivatives conventionally. The benzimidazole nuclei are condensed with various substituted piperazines to obtain targeted benzimidazole–piperazine hybrids. Their anxiolytic activity is determined using the Elevated Plus Maze test and hole board test in mice. All compounds have shown good docking scores and in vivo anxiolytic activity. Conclusion Out of all the derivatives synthesized, compounds 5b, 5c, and 5f exhibited outstanding anxiolytic efficacy in both computational simulations and live subjects. Compound 5b demonstrated a remarkable docking score relative to the ligand, suggesting its potential as a promising candidate warranting further exploration.
AbstractList Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervous system. This study aimed to design, molecularly dock, synthesize, and assess the anxiolytic potential of six derivatives of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole. Results In the present study, an attempt was made to synthesize benzimidazole derivatives conventionally. The benzimidazole nuclei are condensed with various substituted piperazines to obtain targeted benzimidazole–piperazine hybrids. Their anxiolytic activity is determined using the Elevated Plus Maze test and hole board test in mice. All compounds have shown good docking scores and in vivo anxiolytic activity. Conclusion Out of all the derivatives synthesized, compounds 5b, 5c, and 5f exhibited outstanding anxiolytic efficacy in both computational simulations and live subjects. Compound 5b demonstrated a remarkable docking score relative to the ligand, suggesting its potential as a promising candidate warranting further exploration.
Abstract Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervous system. This study aimed to design, molecularly dock, synthesize, and assess the anxiolytic potential of six derivatives of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole. Results In the present study, an attempt was made to synthesize benzimidazole derivatives conventionally. The benzimidazole nuclei are condensed with various substituted piperazines to obtain targeted benzimidazole–piperazine hybrids. Their anxiolytic activity is determined using the Elevated Plus Maze test and hole board test in mice. All compounds have shown good docking scores and in vivo anxiolytic activity. Conclusion Out of all the derivatives synthesized, compounds 5b, 5c, and 5f exhibited outstanding anxiolytic efficacy in both computational simulations and live subjects. Compound 5b demonstrated a remarkable docking score relative to the ligand, suggesting its potential as a promising candidate warranting further exploration.
BackgroundIn contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive literature reviews indicate the diverse biological effects of benzimidazole and piperazine derivatives, notably their impact on the central nervous system. This study aimed to design, molecularly dock, synthesize, and assess the anxiolytic potential of six derivatives of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole.ResultsIn the present study, an attempt was made to synthesize benzimidazole derivatives conventionally. The benzimidazole nuclei are condensed with various substituted piperazines to obtain targeted benzimidazole–piperazine hybrids. Their anxiolytic activity is determined using the Elevated Plus Maze test and hole board test in mice. All compounds have shown good docking scores and in vivo anxiolytic activity.ConclusionOut of all the derivatives synthesized, compounds 5b, 5c, and 5f exhibited outstanding anxiolytic efficacy in both computational simulations and live subjects. Compound 5b demonstrated a remarkable docking score relative to the ligand, suggesting its potential as a promising candidate warranting further exploration.
ArticleNumber 50
Author Unavane, Supriya
Mahajan, Bhavna Sunil
Kawale, Laxman A.
Nade, Vandana S.
Kapadnis, Prajakta
Sajimon, Lida
Author_xml – sequence: 1
  givenname: Bhavna Sunil
  orcidid: 0009-0000-1770-1100
  surname: Mahajan
  fullname: Mahajan, Bhavna Sunil
  email: bhavnamahajan15@gmail.com
  organization: Pharmaceutical Chemistry Department, Vishwakarma University School of Pharmacy
– sequence: 2
  givenname: Laxman A.
  surname: Kawale
  fullname: Kawale, Laxman A.
  organization: Pharmaceutical Chemistry Department, NDMVP Samaja’s College of Pharmacy
– sequence: 3
  givenname: Vandana S.
  surname: Nade
  fullname: Nade, Vandana S.
  organization: Pharmacology Department, NDMVP Samaja’s College of Pharmacy
– sequence: 4
  givenname: Supriya
  surname: Unavane
  fullname: Unavane, Supriya
  organization: Pharmaceutical Chemistry Department, Vishwakarma University School of Pharmacy
– sequence: 5
  givenname: Lida
  surname: Sajimon
  fullname: Sajimon, Lida
  organization: Pharmacy Department, Vishwakarma University School of Pharmacy
– sequence: 6
  givenname: Prajakta
  surname: Kapadnis
  fullname: Kapadnis, Prajakta
  organization: Pharmaceutics Department, Vishwakarma University School of Pharmacy
BookMark eNp9UU1vEzEUtFCRKKV_gNNKXECq6fNHvNkjKpRWqtRLe0LIcuy3iaONvdibiM1_4j_WySLgUg6Wn0Yz855mXpOTEAMS8pbBR8bm6jJLAY2kwMsDxRWFF-SUCyZpzWfi5J_5FTnPeQ0AbC4lV3BKfn3G7JfhospjGFZlzheVCa7Cnem2ZvAxVLEtyE8fu3HwtjJ28Ds_jAeY0_eS9isMY9f7HpPZ-0AZHbsPlN3QBYb9N_fdb7wz-9jh0fcZyQaH1XMyh8nvyik7zG_Iy9Z0Gc9__2fk8frLw9UNvbv_env16Y5awWCgyjEzr2XbcuGcqBtgRtQWGSJXpoQFswWgaZRloBpVMyvcDB0rBCWd5U6ckdvJ10Wz1n3yG5NGHY3XRyCmpTappNGhZnyuZANoF-6Qadu4skRaY7lyaNqD17vJq0_xxxbzoNdxm0I5XwtgogEpZk1h8YllU8w5YftnKwN9aFlPLevSsj62rKGIxCTKhRyWmP5a_0f1BIoArcs
Cites_doi 10.1039/C2CE26120K
10.3390/70700507
10.13140/RG.2.2.25524.55684
10.1016/j.ejmech.2014.07.016
10.13040/IJPSR.0975-8232.1(1).34-38
10.1016/s0091-3057(97)00054-3
10.1016/s0169-409x(00)00129-0
10.2174/1570180819666220929121630
10.1016/j.ejmech.2009.11.053
10.1186/2191-2858-3-7
10.4103/0975-1483.66809
ContentType Journal Article
Copyright The Author(s) 2024
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
DOA
DOI 10.1186/s43094-024-00626-0
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central (subscription)
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 2314-7253
EndPage 9
ExternalDocumentID oai_doaj_org_article_1286490ecbd8442f9de264cac26deafd
10_1186_s43094_024_00626_0
GroupedDBID 0R~
0SF
457
5VS
6I.
7X7
8AO
8FI
8FJ
AACTN
AAFWJ
AAKKN
ABDBF
ABEEZ
ABMAC
ABUWG
ACACY
ACGFS
ACULB
ADBBV
ADEZE
AFGXO
AFKRA
AFPKN
AGHFR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
C24
C6C
CCPQU
EBS
FDB
FYUFA
GROUPED_DOAJ
HMCUK
IAO
IHR
ITC
KQ8
M~E
O9-
OK1
PIMPY
RSV
SOJ
UKHRP
AAYXX
CITATION
PHGZM
PHGZT
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
PUEGO
ID FETCH-LOGICAL-c310t-6d1a874ff23dd37901a37ce1ee26a43005b0ea96c1069671c3d5ed1e1e64dc2d3
IEDL.DBID C6C
ISSN 2314-7253
2314-7245
IngestDate Wed Aug 27 00:48:25 EDT 2025
Mon Jun 30 12:30:53 EDT 2025
Tue Jul 01 00:23:10 EDT 2025
Fri Feb 21 02:44:09 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Piperazines
Benzimidazole derivatives
Anti-anxiety agents
Docking
Health and well-being
Elevated Plus Maze (EPM) test
Hole board test
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c310t-6d1a874ff23dd37901a37ce1ee26a43005b0ea96c1069671c3d5ed1e1e64dc2d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0009-0000-1770-1100
OpenAccessLink https://doi.org/10.1186/s43094-024-00626-0
PQID 3013904359
PQPubID 5642771
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_1286490ecbd8442f9de264cac26deafd
proquest_journals_3013904359
crossref_primary_10_1186_s43094_024_00626_0
springer_journals_10_1186_s43094_024_00626_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-03-29
PublicationDateYYYYMMDD 2024-03-29
PublicationDate_xml – month: 03
  year: 2024
  text: 2024-03-29
  day: 29
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: New Cairo
PublicationTitle Future journal of pharmaceutical sciences
PublicationTitleAbbrev Futur J Pharm Sci
PublicationYear 2024
Publisher Springer Berlin Heidelberg
Springer Nature B.V
SpringerOpen
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
– name: SpringerOpen
References Unavane, Syed, Jain, Bansode (CR13) 2023; 20
Pavia, Lampman, Kirz (CR22) 2007
Bistrisky, Khalsa, Cameron, Sciffman (CR1) 2013; 38
Lipinski, Lombardo, Dominy, Feeney (CR29) 1997; 23
Venkatramana, Singh, Tiwari, Tiwari (CR8) 2010; 1
Kumar, Pathak (CR15) 2012; 1
Barua, Roy (CR24) 2009; 47
Salguirao, Ardenghi (CR5) 1997; 54
CR18
CR12
Chioua, Benabdelouahab, Chioua, Martínez (CR11) 2002; 7
Pai, Diptanshu (CR19) 2012; 2
CR30
Malik, Ahuja (CR21) 2014; 84
CR4
Nannapaneni, Gupta, Reddy (CR26) 2010; 2
Kumar, Bhat, Kumar, Shah (CR9) 2011
Walia, Hedietullah (CR10) 2011; 1
CR28
CR27
Czopek, Byrtus (CR25) 2010; 45
Jain, Jain, Sharma, Saha (CR20) 2011; 3
Rang, Dale, Riter, Flower (CR2) 2003
Xia, Wei, Yang, Qiao (CR23) 2012; 15
Barar (CR7) 2000
Foye, Lamke, Williams (CR6) 1995
Yekkirala, Sudhagani, Panuganti (CR14) 2013; 3
Petkar, Parekh, Mehta (CR17) 2013; 5
Dubey, Naidu, Anandam (CR16) 2005; 44
Tripathi (CR3) 1998
626_CR12
R Pai (626_CR19) 2012; 2
626_CR30
A Bistrisky (626_CR1) 2013; 38
K Kumar (626_CR15) 2012; 1
K Petkar (626_CR17) 2013; 5
626_CR18
R Chioua (626_CR11) 2002; 7
CC Barua (626_CR24) 2009; 47
V Yekkirala (626_CR14) 2013; 3
Z Xia (626_CR23) 2012; 15
JB Salguirao (626_CR5) 1997; 54
C Venkatramana (626_CR8) 2010; 1
R Walia (626_CR10) 2011; 1
KD Tripathi (626_CR3) 1998
DL Pavia (626_CR22) 2007
626_CR4
HP Rang (626_CR2) 2003
FS Barar (626_CR7) 2000
S Malik (626_CR21) 2014; 84
626_CR28
626_CR27
VK Jain (626_CR20) 2011; 3
D Kumar (626_CR9) 2011
PK Dubey (626_CR16) 2005; 44
SA Unavane (626_CR13) 2023; 20
DT Nannapaneni (626_CR26) 2010; 2
WO Foye (626_CR6) 1995
A Czopek (626_CR25) 2010; 45
CA Lipinski (626_CR29) 1997; 23
References_xml – volume: 15
  start-page: 86
  year: 2012
  end-page: 99
  ident: CR23
  article-title: Lanthanide coordination compounds with 1H-benzimidazole-2-carboxylic acid: syntheses, structures and spectroscopic properties
  publication-title: CrystEngComm
  doi: 10.1039/C2CE26120K
– ident: CR18
– volume: 47
  start-page: 969
  year: 2009
  end-page: 973
  ident: CR24
  article-title: Anxiolytic effect of hydroethanolic extract of L Willd
  publication-title: Ind J Exp Biol
– volume: 2
  start-page: 117
  year: 2012
  end-page: 128
  ident: CR19
  article-title: Synthesis of new analysis 3,4-dihydro-quinazolinone derivatives as a typical antidepressant, sedative, and antiparkinsons agents
  publication-title: J Heter Lett
– volume: 7
  start-page: 507
  issue: 2002
  year: 2002
  end-page: 510
  ident: CR11
  article-title: Piperazine
  publication-title: Molecules
  doi: 10.3390/70700507
– ident: CR4
– year: 2011
  ident: CR9
  article-title: Nature: anxiolytics in the lap of nature
  publication-title: Webmedcentral Pharm Sci
  doi: 10.13140/RG.2.2.25524.55684
– ident: CR12
– ident: CR30
– year: 1998
  ident: CR3
  publication-title: Essential of medicinal pharmacology
– volume: 84
  start-page: 42
  year: 2014
  end-page: 50
  ident: CR21
  article-title: Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants
  publication-title: Euro J Med Chem
  doi: 10.1016/j.ejmech.2014.07.016
– year: 2007
  ident: CR22
  publication-title: Introduction to spectroscopy
– volume: 1
  start-page: 34
  year: 2010
  end-page: 38
  ident: CR8
  article-title: Synthesis of phenyl hydrazine substituted benzimidazole derivatives and their biological activity
  publication-title: IJPSR
  doi: 10.13040/IJPSR.0975-8232.1(1).34-38
– volume: 54
  start-page: 887
  issue: 4
  year: 1997
  end-page: 891
  ident: CR5
  article-title: Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effects on memory tasks in rats
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/s0091-3057(97)00054-3
– volume: 1
  start-page: 44
  year: 2012
  end-page: 50
  ident: CR15
  article-title: Synthesis characterization and evaluation of 2-substituted benzimidazole derivative
  publication-title: Pharma Innov
– ident: CR27
– volume: 5
  start-page: 115
  year: 2013
  end-page: 119
  ident: CR17
  article-title: Synthesis and evaluation of 2-chloromethyl-1h-benzimidazole derivatives as antifungal agents
  publication-title: Int J Pharm Pharm Sci
– volume: 23
  start-page: 4
  year: 1997
  end-page: 25
  ident: CR29
  article-title: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/s0169-409x(00)00129-0
– volume: 20
  start-page: 2025
  issue: 12
  year: 2023
  end-page: 2033
  ident: CR13
  article-title: Docking and pharmacokinetic studies for screening terpenoids from erythroxylum species as anticancer agents
  publication-title: Lett Drug Des Discov
  doi: 10.2174/1570180819666220929121630
– volume: 3
  start-page: 66
  year: 2011
  end-page: 70
  ident: CR20
  article-title: Synthesis characterization and antimicrobial screening of some 4-substituted 1(4substituted phenyl) piperazine derivatives
  publication-title: Int J Curr Pharm Res
– volume: 38
  start-page: 30
  issue: 1
  year: 2013
  end-page: 38
  ident: CR1
  article-title: Current diagnosis and treatment of anxiety disorders
  publication-title: Pharm Ther
– volume: 44
  start-page: 1239
  issue: B
  year: 2005
  end-page: 1242
  ident: CR16
  article-title: Synthesis of 1- (n-hexyl-5-one)-2 chlorobenzimidazole
  publication-title: Ind J Chem
– year: 1995
  ident: CR6
  publication-title: Principles of medicinal chemistry
– year: 2003
  ident: CR2
  publication-title: Rang and dells pharmacology
– volume: 45
  start-page: 1295
  year: 2010
  end-page: 1303
  ident: CR25
  article-title: Synthesis and pharmacological evaluation of new 5-(cyclo) alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity
  publication-title: Euro J Med Chem
  doi: 10.1016/j.ejmech.2009.11.053
– year: 2000
  ident: CR7
  publication-title: Essentials of pharmacotherapeutics
– volume: 3
  start-page: 1
  year: 2013
  end-page: 8
  ident: CR14
  article-title: Facile and efficient one-pot synthesis of benzimidazoles using lanthanum chloride
  publication-title: Org Med Chem Lett
  doi: 10.1186/2191-2858-3-7
– volume: 2
  start-page: 273
  year: 2010
  end-page: 279
  ident: CR26
  article-title: Synthesis, characterization, and biological evaluation of Benzimidazole derivatives as potential anxiolytics
  publication-title: J Young Pharm
  doi: 10.4103/0975-1483.66809
– volume: 1
  start-page: 3565
  year: 2011
  end-page: 3574
  ident: CR10
  article-title: Benzimidazole derivatives: an overview
  publication-title: IJRPC
– ident: CR28
– volume-title: Principles of medicinal chemistry
  year: 1995
  ident: 626_CR6
– ident: 626_CR18
– volume: 84
  start-page: 42
  year: 2014
  ident: 626_CR21
  publication-title: Euro J Med Chem
  doi: 10.1016/j.ejmech.2014.07.016
– volume: 15
  start-page: 86
  year: 2012
  ident: 626_CR23
  publication-title: CrystEngComm
  doi: 10.1039/C2CE26120K
– ident: 626_CR12
– volume: 44
  start-page: 1239
  issue: B
  year: 2005
  ident: 626_CR16
  publication-title: Ind J Chem
– volume: 54
  start-page: 887
  issue: 4
  year: 1997
  ident: 626_CR5
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/s0091-3057(97)00054-3
– volume: 1
  start-page: 3565
  year: 2011
  ident: 626_CR10
  publication-title: IJRPC
– volume: 38
  start-page: 30
  issue: 1
  year: 2013
  ident: 626_CR1
  publication-title: Pharm Ther
– volume: 23
  start-page: 4
  year: 1997
  ident: 626_CR29
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/s0169-409x(00)00129-0
– volume: 5
  start-page: 115
  year: 2013
  ident: 626_CR17
  publication-title: Int J Pharm Pharm Sci
– year: 2011
  ident: 626_CR9
  publication-title: Webmedcentral Pharm Sci
  doi: 10.13140/RG.2.2.25524.55684
– volume: 3
  start-page: 66
  year: 2011
  ident: 626_CR20
  publication-title: Int J Curr Pharm Res
– ident: 626_CR27
– volume: 1
  start-page: 34
  year: 2010
  ident: 626_CR8
  publication-title: IJPSR
  doi: 10.13040/IJPSR.0975-8232.1(1).34-38
– volume: 1
  start-page: 44
  year: 2012
  ident: 626_CR15
  publication-title: Pharma Innov
– volume: 7
  start-page: 507
  issue: 2002
  year: 2002
  ident: 626_CR11
  publication-title: Molecules
  doi: 10.3390/70700507
– volume: 20
  start-page: 2025
  issue: 12
  year: 2023
  ident: 626_CR13
  publication-title: Lett Drug Des Discov
  doi: 10.2174/1570180819666220929121630
– volume: 2
  start-page: 117
  year: 2012
  ident: 626_CR19
  publication-title: J Heter Lett
– volume-title: Rang and dells pharmacology
  year: 2003
  ident: 626_CR2
– volume-title: Essential of medicinal pharmacology
  year: 1998
  ident: 626_CR3
– volume: 47
  start-page: 969
  year: 2009
  ident: 626_CR24
  publication-title: Ind J Exp Biol
– ident: 626_CR30
– volume-title: Essentials of pharmacotherapeutics
  year: 2000
  ident: 626_CR7
– volume: 45
  start-page: 1295
  year: 2010
  ident: 626_CR25
  publication-title: Euro J Med Chem
  doi: 10.1016/j.ejmech.2009.11.053
– volume: 3
  start-page: 1
  year: 2013
  ident: 626_CR14
  publication-title: Org Med Chem Lett
  doi: 10.1186/2191-2858-3-7
– ident: 626_CR4
– ident: 626_CR28
– volume: 2
  start-page: 273
  year: 2010
  ident: 626_CR26
  publication-title: J Young Pharm
  doi: 10.4103/0975-1483.66809
– volume-title: Introduction to spectroscopy
  year: 2007
  ident: 626_CR22
SSID ssj0001844260
Score 2.25887
Snippet Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive...
BackgroundIn contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states. Extensive...
Abstract Background In contemporary society, anxiety has become a widespread disorder leading to compromised well-being and heightened depressive states....
SourceID doaj
proquest
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 50
SubjectTerms Anti-anxiety agents
Antifungal agents
Anxiety
Benzimidazole derivatives
Benzodiazepines
Biological activity
Chromatography
Docking
Elevated Plus Maze (EPM) test
Hole board test
Ligands
Mass spectrometry
Medicine
Medicine & Public Health
NMR
Nuclear magnetic resonance
Piperazines
Proteins
Scientific imaging
Software
Statistical analysis
Well being
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS-QwFA7iyYvs6oqz_iCHRVacYNrEtD36Y2VYWPGgIIiEJC-FwtgZ7Oxi53_yf_QlnXF0YdjLHnpJX9LQ97X5Xpv3PUK-KeNtYBLMOeBMJsYxI8Ay4xExwnNvVchG_nWlBrfy593J3btSX2FPWCcP3N24Y3x_Kllw7yzkUqZlAR7XcGdcqsCbEsLbF9e8d8FU_LoSbBWfZ8nk6riRggcV3BQPjiye8Q8rURTs_8Ay__oxGteby09kfUYU6Wk3wc9kxdcb5OC6U5pu-_RmkTjV9OkBvV5oULeb5OUi7szo06atkeI1FdqYGuhC3JuOSmx5rkbDFoegIb8hlJEIzSn7LlnY-9UOx9UYLzOtaowB2-EhSwbM-np6Dw_VYwVmOhr6OO6SLqE-9bJugNj_E2XHmy_k9vLHzfmAzSozMId0cMIUJCbPZFmmAkBkyCmMyJxPPPrGyKCAb7k3hXIYcBYqS5yAEw8JGigJLgWxRVbrUe23Cc25M6nLLQ6XSedKk1sps8IiNUQPQtkjR3Mv6XEnwKFj4JIr3flUo0919KnmPXIWHPlmGcSzYwNCSs8gpf8FqR7ZncNAz57oRovAlTmSy6JH-nNoLE4vn9LX_zGlHbKWRuiGwnu7ZHXy9NvvIRua2P0I_Fcx8wmI
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXLggnmKhIB9QBWKtOrHXSU4VLVQrJFAPrbQSQpZfQZGWZGm2Fdn_xH_sjDchKtJyyMWxx5Zm7Pn8mG8IeaNMsIgkmHOeM5kYx4zwlpkAFiMCD1ZhNPKXr2p-IT8vZov-wK3tn1UOa2JcqH3j8Iz8UCBW4eDci6PVL4ZZo_B2tU-hcZfcQ-oytOpskY1nLLlEAvaYXy6RLEvlbIibydVhKwVHXtwUPg64nvFbvilS-N_Cnf9clUYPdPqQPOihI_2w1fUjcifUj8nB2ZZ7upvS8zGUqp3SA3o2slJ3T8ifj_GtxpS2XQ2gr62gjqk9Hem-aVNCye-qWXYggmLEAyaWwOKUvZUMX4N1y1W1gm42VQ27wm75jiVzZkO9-ea_Vz8rbzbNMkS5O5pgxupdzTzMhutIRN4-JRenn85P5qzP1cAcAMQ1Uz4xeSbLMhXeiwxQhhGZC0kIqTISOfEtD6ZQDraghcoSJ_ws-AQqKOld6sUzslc3dXhOaM6dSV1uQVwmnStNbqXMCgtgEbTpywl5P2hJr7aUHDpuZXKltzrVoFMddar5hByjIv_WRDrtWNBc_tD97NTgpJUseHDWo8mUhYdhS2cc9BdM6SdkfzAD3c_xVo8WOSHTwTTG37uH9OL_0l6S-2k0Skyyt0_21pdX4RUgn7V9Hc37BjHVAZw
  priority: 102
  providerName: ProQuest
Title Design, synthesis, and evaluation of anxiolytic activity of 2-(4-phenylpiperazin-1-yl)-1H-benz[d]imidazole and 2-(4-phenylpiperazin-1-methyl)-1H-benz[d]imidazole derivatives
URI https://link.springer.com/article/10.1186/s43094-024-00626-0
https://www.proquest.com/docview/3013904359
https://doaj.org/article/1286490ecbd8442f9de264cac26deafd
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA_agvgiWhVP65EHKYoXzG5yye6jPVsOpeWUFg5EQr4WFq57h3st7v1P_R87ye25bfEefNiFzU4-YCbkN0nmNwi9E9qbgCSItY4SnmhLNHOGaA8Wwzz1RoRo5JNTMT7nX6fDaUuTE2Jhbp_fJ5n4VHNGA3ltCg8F8E3APd8dJkyGNA0jMer2UzIeyNY3cTH_rHpn7YkU_Xdw5b2j0LjCHD9FT1poiD-vdfkMPfDVHnp00h5-76GDyZpmuhngsy5qqh7gAzzpCKib5-j6S7yWMcB1UwG-q0uQ0ZXDHbM3nhdQ8qeczxpoAofghpBDIhSn5D0n4eJXM1uUC-hmVVbgADazDyQZE-Or1U_3q7wonV7NZz62u6VKSE69rZoDw7-KnOP1C3R-fHQ2GpM2LQOxgAWXRLhEZ5IXRcqcYxIAhWbS-sT7VGge6O8N9ToXFrzNXMjEMjf0LgEBwZ1NHXuJdqp55V8hnFGrU5sZaE5yawudGc5lbgAXgjJd0UMfNwpTizX7hopeSybUWr0K1KuiehXtocOg07-SgTk7FoBBqXYiKliPBc-pt8YFiylyB8PmVlvoz-vC9dD-xiJUO51rxQJQpoAs8x4abKyk-719SK__T_wNepxGew359fbRzvL3pX8LoGdp-uihnMo-2j08Op38gK9RyvtxBvTjNgK8v33PbgBE0gEF
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOcAF8RQLBXyACsRadRyvkxwQAkq1pQ_1sJVWQsj1KyjSkizN8sj-J_iNjJ0NUZGWWw-5OPY40ow93ziebxB6KpTTHkkQYywlPFKGqNhqohxYTOyo08JnIx8di_Ep_zAdTTfQ7y4Xxl-r7PbEsFHbyvgz8p3YYxUKzj17Pf9KfNUo_3e1K6HRmsWBa35AyFa_2t8F_T5jbO_95N2YrKoKEANQZkGEjVSa8DxnsbVxAv5QxYlxkXNMKO7Z2zV1KhMGgqVMJJGJ7cjZCDoIbg2zMci9gq6C46U-2EumSX-mk3JP-B7q2UWcJIyPujydVOzUINzz8DJ4KMQRhF7whaFkwAWc-8-v2eDx9m6iGyuoit-0tnULbbjyNto-abmumyGe9Klb9RBv45OeBbu5g37thrshQ1w3JYDMuoA-qrS4pxfHVQ4tP4tq1oAI7DMsfCEL38zIc0787bNmNi_mMM2yKCEKbWYvSDQm2pXLj_ZT8aWwalnNXJC7ZoivkL1umIXV9z0Qn9d30emlaPEe2iyr0t1HOKVGMZNqEJdwY3KVas6TTAM4BW3afIBedlqS85YCRIbQKRWy1akEncqgU0kH6K1X5N-enr47NFTnn-VqN5AACgTPqDPaepPJMwufzY0yMJ9TuR2grc4M5GpPqWW_AgZo2JlG_3r9Jz34v7Qn6Np4cnQoD_ePDx6i6ywYqC_wt4U2F-ff3CNAXQv9OJg6RmeXvbb-ALmGPmU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJyFeEFdRNiAPMIGo1cRxneQBIUZXdQyqCm3SJDQZ34IidUlZyiX9T_wBfh3HTkI0pPK2h7w49rGlc2x_x_b5DkJPmTDSIgmslPYxDYTCItQSCwMWExrfSGajkT_M2PSEvjsdnW6h320sjH1W2a6JbqHWhbJn5MPQYhUfNvdkmDbPIubjyevlV2wzSNmb1jadRm0iR6b6Ae5b-epwDLp-Rsjk4PjtFDcZBrACWLPCTAcijmiaklDrMIK9UYSRMoExhAlqmdylb0TCFDhOCYsCFeqR0QFUYFQrokOQew1tR9Yr6qHt_YPZ_GN3whNTS__ustsFFEeEjtqonZgNSxBvWXkJfD54Fdi_tDO6BAKXUO8_F7Vu_5vcQjcb4Oq9qS3tNtoy-R20N6-Zr6uBd9wFcpUDb8-bd5zY1V30a-xeigy8ssoBcpYZ1BG59jqyca9IoeRnViwqEOHZeAub1sIWE_ycYvsWrVossyV0s85y8EmrxQscTLE0-fqTPsvOMy3WxcI4uRua2HzZm5ppmIvfHQ16eQ-dXIke76NeXuTmAfJiXwmiYgniIqpUKmJJaZRIgKqgTZ320ctWS3xZE4Jw50jFjNc65aBT7nTK_T7at4r8W9OSebuC4uILb9YGDhCB0cQ3SmprMmmiYdhUCQX9GZHqPtptzYA3K0zJu_nQR4PWNLrfm4f08P_SnqDrMK_4-8PZ0Q66QZx92mx_u6i3uvhmHgEEW8nHja176PNVT68_CDdEAA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design%2C+synthesis%2C+and+evaluation+of+anxiolytic+activity+of+2-%284-phenylpiperazin-1-yl%29-1H-benz%5Bd%5Dimidazole+and+2-%284-phenylpiperazin-1-methyl%29-1H-benz%5Bd%5Dimidazole+derivatives&rft.jtitle=Future+journal+of+pharmaceutical+sciences&rft.au=Mahajan%2C+Bhavna+Sunil&rft.au=Kawale%2C+Laxman+A.&rft.au=Nade%2C+Vandana+S.&rft.au=Unavane%2C+Supriya&rft.date=2024-03-29&rft.pub=Springer+Berlin+Heidelberg&rft.eissn=2314-7253&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1186%2Fs43094-024-00626-0&rft.externalDocID=10_1186_s43094_024_00626_0
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2314-7253&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2314-7253&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2314-7253&client=summon